Induction of Viral Mimicry Upon Loss of DHX9 and ADAR1 in Breast Cancer Cells
Published version of a preprint
The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
Detection of viral double-stranded RNA (dsRNA) is an important component of innate immunity. However, many endogenous RNAs containing double-stranded regions can be misrecognized and activate innate immunity. The IFN-inducible ADAR1-p150 suppresses dsRNA sensing, an essential function for adenosine deaminase acting on RNA 1 (ADAR1) in many cancers, including breast. Although ADAR1-p150 has been well established in this role, the functions of the constitutively expressed ADAR1-p110 isoform are less understood. We used proximity labeling to identify putative ADAR1-p110–interacting proteins in breast cancer cell lines. Of the proteins identified, the RNA helicase DHX9 was of particular interest. Knockdown of DHX9 in ADAR1-dependent cell lines caused cell death and activation of the dsRNA sensor PKR. In ADAR1-independent cell lines, combined knockdown of DHX9 and ADAR1, but neither alone, caused activation of multiple dsRNA sensing pathways leading to a viral mimicry phenotype. Together, these results reveal an important role for DHX9 in suppressing dsRNA sensing by multiple pathways. Significance: These findings implicate DHX9 as a suppressor of dsRNA sensing. In some cell lines, loss of DHX9 alone is sufficient to cause activation of dsRNA sensing pathways, while in other cell lines DHX9 functions redundantly with ADAR1 to suppress pathway activation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Several proteomics studies have defined the ADAR interactomes [20–23], identifying associations with RNA-binding proteins, helicases, and factors involved in RNA processing.”
From ADAR1 and ADAR2 associate with the RNA exosome and modulate RNA stability (2026) · cites this paper as [22]
In the citing paper
“This interaction between the RNA exosome and ADAR1 had been previously reported through mass spectrometry analyses, but these interactions have not been further studied [20–25].”
From ADAR1 and ADAR2 associate with the RNA exosome and modulate RNA stability (2026) · cites this paper as [22]
In the citing paper
“However, until now a direct mechanistic link between the RNA exosome and ADARs has not been established.”
From ADAR1 and ADAR2 associate with the RNA exosome and modulate RNA stability (2026) · cites this paper as [22]
In the citing paper
“While EXOSC10 has repeatedly appeared in ADARs interaction datasets [20–23], the catalytic subunit DIS3 was not detected in our co-IP/MS analysis but has been reported as an HCI in ADAR1 BioID experiment [21].”
From ADAR1 and ADAR2 associate with the RNA exosome and modulate RNA stability (2026) · cites this paper as [22]
In the citing paper
“Our findings are corroborated by several previous high-throughput studies that employed either ADARs or RNA exosome components as bait and reported similar links but did not explore these interactions further [20–25].”
From ADAR1 and ADAR2 associate with the RNA exosome and modulate RNA stability (2026) · cites this paper as [22]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
Love, M. I., Huber, W., & Anders, S. (2014) · Genome Biology · doi:10.1186/s13059-014-0550-8 · Cited by 95,106
Next-generation characterization of the Cancer Cell Line Encyclopedia
Ghandi, M., Huang, F. W., Jané-Valbuena, J., Kryukov, G. V., Lo, C. C., McDonald, E. R., Barretina, J., Gelfand, E. T., Bielski, C. M., Li, H., et al. (2019) · Nature · doi:10.1038/s41586-019-1186-3 · Cited by 3,394
The integrated stress response
Pakos‐Zebrucka, K., Koryga, I., Mnich, K., Ljujic, M., Samali, A., & Gorman, A. M. (2016) · The EMBO Reports · doi:10.15252/embr.201642195 · Cited by 2,659
CDK4/6 inhibition triggers anti-tumour immunity
Goel, S., DeCristo, M. J., Watt, A. C., BrinJones, H., Sceneay, J., Li, B. B., Khan, N., Ubellacker, J. M., Xie, S., Metzger-Filho, O., et al. (2017) · Nature · doi:10.1038/nature23465 · Cited by 1,513
Impact of Protein Kinase PKR in Cell Biology: from Antiviral to Antiproliferative Action
García, M. A., Gil, J., Ventoso, I., Guerra, S., Domingo, E., Rivas, C., & Esteban, M. (2006) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00027-06 · Cited by 818
LSD1 Ablation Stimulates Anti-tumor Immunity and Enables Checkpoint Blockade
Sheng, W., LaFleur, M. W., Nguyen, T. H., Chen, S., Chakravarthy, A., Conway, J. R., Li, Y., Chen, H., Yang, H., Hsu, P.-H., et al. (2018) · Cell · doi:10.1016/j.cell.2018.05.052 · Cited by 693
Human ADAR1 Prevents Endogenous RNA from Triggering Translational Shutdown
Chung, H., Calis, J. J. A., Wu, X., Sun, T., Yu, Y., Sarbanes, S. L., Dao Thi, V. L., Shilvock, A. R., Hoffmann, H.-H., Rosenberg, B. R., et al. (2018) · Cell · doi:10.1016/j.cell.2017.12.038 · Cited by 538
Zhou, X., Singh, M., Sanz Santos, G., Guerlavais, V., Carvajal, L. A., Aivado, M., Zhan, Y., Oliveira, M. M. S., Westerberg, L. S., Annis, D. A., et al. (2021) · Cancer Discovery · doi:10.1158/2159-8290.cd-20-1741 · Cited by 169
Research works printed but not linked: 83
- Paz-Yaacov, 2015, Elevated RNA editing activity is a major contributor to transcriptomic diversity in tumors, Cell Rep, 13, 267, 10.1016/j.celrep.2015.08.080 · DOI · Paper page
- Walkley, 2017, Rewriting the transcriptome: adenosine-to-inosine RNA editing by ADARs, Genome Biol, 18, 205, 10.1186/s13059-017-1347-3 · DOI · Paper page
- Li, 2011, Widespread RNA and DNA sequence differences in the human transcriptome, Science, 333, 53, 10.1126/science.1207018 · DOI · Paper page
- Bazak, 2014, A-to-I RNA editing occurs at over a hundred million genomic sites, located in a majority of human genes, Genome Res, 24, 365, 10.1101/gr.164749.113 · DOI · Paper page
- Wagner, 1989, A double-stranded RNA unwinding activity introduces structural alterations by means of adenosine to inosine conversions in mammalian cells and Xenopus eggs, Proc Natl Acad Sci U S A, 86, 2647, 10.1073/pnas.86.8.2647 · DOI · Paper page
- Kim, 1994, Molecular cloning of cDNA for double-stranded RNA adenosine deaminase, a candidate enzyme for nuclear RNA editing, Proc Natl Acad Sci U S A, 91, 11457, 10.1073/pnas.91.24.11457 · DOI · Paper page
- Herbert, 1997, A Z-DNA binding domain present in the human editing enzyme, double-stranded RNA adenosine deaminase, Proc Natl Acad Sci U S A, 94, 8421, 10.1073/pnas.94.16.8421 · DOI · Paper page
- George, 1999, Human RNA-specific adenosine deaminase ADAR1 transcripts possess alternative exon 1 structures that initiate from different promoters, one constitutively active and the other interferon inducible, Proc Natl Acad Sci U S A, 96, 4621, 10.1073/pnas.96.8.4621 · DOI · Paper page
- Desterro, 2003, Dynamic association of RNA-editing enzymes with the nucleolus, J Cell Sci, 116, 1805, 10.1242/jcs.00371 · DOI · Paper page
- Patterson, 1995, Expression and regulation by interferon of a double-stranded-RNA-specific adenosine deaminase from human cells: evidence for two forms of the deaminase, Mol Cell Biol, 15, 5376, 10.1128/MCB.15.10.5376 · DOI · Paper page
- Eckmann, 2001, The human but not the Xenopus RNA-editing enzyme ADAR1 has an atypical nuclear localization signal and displays the characteristics of a shuttling protein, Mol Biol Cell, 12, 1911, 10.1091/mbc.12.7.1911 · DOI
- Liddicoat, 2015, RNA editing by ADAR1 prevents MDA5 sensing of endogenous dsRNA as nonself, Science, 349, 1115, 10.1126/science.aac7049 · DOI · Paper page
- Pestal, 2015, Isoforms of the RNA editing enzyme ADAR1 independently control nucleic acid sensor MDA5-driven autoimmunity and multi-organ development, Immunity, 43, 933, 10.1016/j.immuni.2015.11.001 · DOI · Paper page
- Mannion, 2014, The RNA-editing enzyme ADAR1 controls innate immune responses to RNA, Cell Rep, 9, 1482, 10.1016/j.celrep.2014.10.041 · DOI · Paper page
- Chen, 2022, Cellular origins of dsRNA, their recognition and consequences, Nat Rev Mol Cell Biol, 23, 286, 10.1038/s41580-021-00430-1 · DOI · Paper page
- Yang, 2014, Adenosine deaminase acting on RNA 1 limits RIG-I RNA detection and suppresses IFN production responding to viral and endogenous RNAs, J Immunol, 193, 3436, 10.4049/jimmunol.1401136 · DOI · Paper page
- George, 2016, Editing of cellular self-RNAs by adenosine deaminase ADAR1 suppresses innate immune stress responses, J Biol Chem, 291, 6158, 10.1074/jbc.M115.709014 · DOI
- Clerzius, 2009, ADAR1 interacts with PKR during human immunodeficiency virus infection of lymphocytes and contributes to viral replication, J Virol, 83, 10119, 10.1128/JVI.02457-08 · DOI
- Quin, 2021, ADAR RNA modifications, the epitranscriptome and innate immunity, Trends Biochem Sci, 46, 758, 10.1016/j.tibs.2021.02.002 · DOI · Paper page
- Montavon, 2021, Human DICER helicase domain recruits PKR and modulates its antiviral activity, PLOS Pathog, 17, e1009549, 10.1371/journal.ppat.1009549 · DOI
- Liu, 2019, Tumor-derived IFN triggers chronic pathway agonism and sensitivity to ADAR loss, Nat Med, 25, 95, 10.1038/s41591-018-0302-5 · DOI · Paper page
- Nakahama, 2021, Mutations in the adenosine deaminase ADAR1 that prevent endogenous Z-RNA binding induce Aicardi-Goutières-syndrome-like encephalopathy, Immunity, 54, 1976, 10.1016/j.immuni.2021.08.022 · DOI
- Li, 2017, Ribonuclease L mediates the cell-lethal phenotype of double-stranded RNA editing enzyme ADAR1 deficiency in a human cell line, Elife, 6, e25687, 10.7554/eLife.25687 · DOI · Paper page
- Rath, 2019, Concerted 2–5A-mediated mRNA decay and transcription reprogram protein synthesis in the dsRNA response, Mol Cell, 75, 1218, 10.1016/j.molcel.2019.07.027 · DOI
- Schoggins, 2011, Interferon-stimulated genes and their antiviral effector functions, Curr Opin Virol, 1, 519, 10.1016/j.coviro.2011.10.008 · DOI · Paper page
- George, 2008, Organization of the mouse RNA-specific adenosine deaminase Adar1 gene 5′-region and demonstration of STAT1-independent, STAT2-dependent transcriptional activation by interferon, Virology, 380, 338, 10.1016/j.virol.2008.07.029 · DOI
- Sun, 2021, Decoupling expression and editing preferences of ADAR1 p150 and p110 isoforms, Proc Natl Acad Sci U S A, 118, e2021757118, 10.1073/pnas.2021757118 · DOI
- Shiromoto, 2021, ADAR1 RNA editing enzyme regulates R-loop formation and genome stability at telomeres in cancer cells, Nat Commun, 12, 1654, 10.1038/s41467-021-21921-x · DOI · Paper page
- Fumagalli, 2015, Principles governing A-to-I RNA editing in the breast cancer transcriptome, Cell Rep, 13, 277, 10.1016/j.celrep.2015.09.032 · DOI · Paper page
- Kung, 2018, The role of RNA editing in cancer development and metabolic disorders, Front Endocrinol, 9, 762, 10.3389/fendo.2018.00762 · DOI
- Paz, 2007, Altered adenosine-to-inosine RNA editing in human cancer, Genome Res, 17, 1586, 10.1101/gr.6493107 · DOI · Paper page
- Chan, 2014, A disrupted RNA editing balance mediated by ADARs (Adenosine DeAminases that act on RNA) in human hepatocellular carcinoma, Gut, 63, 832, 10.1136/gutjnl-2012-304037 · DOI · Paper page
- Gannon, 2018, Identification of ADAR1 adenosine deaminase dependency in a subset of cancer cells, Nat Commun, 9, 5450, 10.1038/s41467-018-07824-4 · DOI · Paper page
- Kung, 2021, Evaluating the therapeutic potential of ADAR1 inhibition for triple-negative breast cancer, Oncogene, 40, 189, 10.1038/s41388-020-01515-5 · DOI
- Ota, 2013, ADAR1 forms a complex with Dicer to promote microRNA processing and RNA-induced gene silencing, Cell, 153, 575, 10.1016/j.cell.2013.03.024 · DOI · Paper page
- Freund, 2020, Unbiased identification of trans regulators of ADAR and A-to-I RNA editing, Cell Rep, 31, 107656, 10.1016/j.celrep.2020.107656 · DOI · Paper page
- Sakurai, 2017, ADAR1 controls apoptosis of stressed cells by inhibiting Staufen1-mediated mRNA decay, Nat Struct Mol Biol, 24, 534, 10.1038/nsmb.3403 · DOI · Paper page
- Jimeno, 2021, ADAR-mediated RNA editing of DNA:RNA hybrids is required for DNA double strand break repair, Nat Commun, 12, 5512, 10.1038/s41467-021-25790-2 · DOI · Paper page
- Hong, 2018, Bidirectional regulation of adenosine-to-inosine (A-to-I) RNA editing by DEAH box helicase 9 (DHX9) in cancer, Nucleic Acids Res, 46, 7953, 10.1093/nar/gky396 · DOI · Paper page
- Rajendren, 2018, A protein–protein interaction underlies the molecular basis for substrate recognition by an adenosine-to-inosine RNA-editing enzyme, Nucleic Acids Res, 46, 9647, 10.1093/nar/gky800 · DOI
- Sapiro, 2020, Zinc finger RNA-binding protein Zn72D regulates ADAR-mediated RNA editing in neurons, Cell Rep, 31, 107654, 10.1016/j.celrep.2020.107654 · DOI
- Shamay-Ramot, 2015, Fmrp interacts with adar and regulates RNA editing, synaptic density and locomotor activity in zebrafish, PLoS Genet, 11, e1005702, 10.1371/journal.pgen.1005702 · DOI · Paper page
- Sanjana, 2014, Improved vectors and genome-wide libraries for CRISPR screening, Nat Methods, 11, 783, 10.1038/nmeth.3047 · DOI · Paper page
- Hayer, 2016, Engulfed cadherin fingers are polarized junctional structures between collectively migrating endothelial cells, Nat Cell Biol, 18, 1311, 10.1038/ncb3438 · DOI · Paper page
- Ong, 2021, Synonymous Mutation Generator: a web tool for designing RNAi-resistant sequences, 10.1101/2021.01.02.425100 · DOI
- Kuleshov, 2016, Enrichr: a comprehensive gene set enrichment analysis web server 2016 update, Nucleic Acids Res, 44, W90, 10.1093/nar/gkw377 · DOI · Paper page
- Zhu, 2019, Heavy-tailed prior distributions for sequence count data: removing the noise and preserving large differences, Bioinformatics, 35, 2084, 10.1093/bioinformatics/bty895 · DOI · Paper page
- Wu, 2021, clusterProfiler 4.0: a universal enrichment tool for interpreting omics data, Innovation, 2, 100141
- Jin, 2015, TEtranscripts: a package for including transposable elements in differential expression analysis of RNA-seq datasets, Bioinformatics, 31, 3593, 10.1093/bioinformatics/btv422 · DOI · Paper page
- Cottrell, 2021, 8-azaadenosine and 8-chloroadenosine are not selective inhibitors of ADAR, Cancer Res Commun, 1, 56, 10.1158/2767-9764.CRC-21-0027 · DOI
- Marcotte, 2016, Functional genomic landscape of human breast cancer drivers, vulnerabilities, and resistance, Cell, 164, 293, 10.1016/j.cell.2015.11.062 · DOI · Paper page
- Lam, 2015, Directed evolution of APEX2 for electron microscopy and proximity labeling, Nat Methods, 12, 51, 10.1038/nmeth.3179 · DOI · Paper page
- Orre, 2019, SubCellBarCode: proteome-wide mapping of protein localization and relocalization, Mol Cell, 73, 166, 10.1016/j.molcel.2018.11.035 · DOI · Paper page
- Poulsen, 2001, CRM1 mediates the export of ADAR1 through a nuclear export signal within the Z-DNA binding domain, Mol Cell Biol, 21, 7862, 10.1128/MCB.21.22.7862-7871.2001 · DOI · Paper page
- Strehblow, 2002, Nucleocytoplasmic distribution of human RNA-editing enzyme ADAR1 is modulated by double-stranded RNA-binding domains, a leucine-rich export signal, and a putative dimerization domain, Mol Biol Cell, 13, 3822, 10.1091/mbc.e02-03-0161 · DOI · Paper page
- Nicholson, 1995, Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis, Nature, 376, 37, 10.1038/376037a0 · DOI · Paper page
- Lazebnik, 1994, Cleavage of poly(ADP-ribose) polymerase by a proteinase with properties like ICE, Nature, 371, 346, 10.1038/371346a0 · DOI · Paper page
- Aktaş, 2017, DHX9 suppresses RNA processing defects originating from the Alu invasion of the human genome, Nature, 544, 115, 10.1038/nature21715 · DOI · Paper page
- Iordanov, 2000, Activation of p38 mitogen-activated protein kinase and c-Jun NH(2)-terminal kinase by double-stranded RNA and encephalomyocarditis virus: involvement of RNase L, protein kinase R, and alternative pathways, Mol Cell Biol, 20, 617, 10.1128/MCB.20.2.617-627.2000 · DOI · Paper page
- Karasik, 2021, Activation of the antiviral factor RNase L triggers translation of non-coding mRNA sequences, Nucleic Acids Res, 49, 6007, 10.1093/nar/gkab036 · DOI
- Burke, 2021, RNase L limits host and viral protein synthesis via inhibition of mRNA export, Sci Adv, 7, eabh2479, 10.1126/sciadv.abh2479 · DOI
- Nakajima, 1997, RNA helicase A mediates association of CBP with RNA polymerase II, Cell, 90, 1107, 10.1016/S0092-8674(00)80376-1 · DOI · Paper page
- Cristini, 2018, RNA/DNA hybrid interactome identifies DXH9 as a molecular player in transcriptional termination and R-loop-associated DNA damage, Cell Rep, 23, 1891, 10.1016/j.celrep.2018.04.025 · DOI · Paper page
- Lee, 2016, The biology of DHX9 and its potential as a therapeutic target, Oncotarget, 7, 42716, 10.18632/oncotarget.8446 · DOI · Paper page
- Ren, 2023, Nucleic DHX9 cooperates with STAT1 to transcribe interferon-stimulated genes, Sci Adv, 9, eadd5005, 10.1126/sciadv.add5005 · DOI
- Zhang, 2011, DHX9 Pairs with IPS-1 to sense double-stranded RNA in myeloid dendritic cells, J Immunol, 187, 4501, 10.4049/jimmunol.1101307 · DOI · Paper page
- Harding, 2000, Regulated translation initiation controls stress-induced gene expression in mammalian cells, Mol Cell, 6, 1099, 10.1016/S1097-2765(00)00108-8 · DOI · Paper page
- Zamanian-Daryoush, 2000, NF-κB activation by double-stranded-RNA-activated protein kinase (PKR) is mediated through NF-κB-inducing kinase and IκB kinase, Mol Cell Biol, 20, 1278, 10.1128/MCB.20.4.1278-1290.2000 · DOI · Paper page
- Lemaire, 2008, Mechanism of PKR activation by dsRNA, J Mol Biol, 381, 351, 10.1016/j.jmb.2008.05.056 · DOI · Paper page
- Kato, 2008, Length-dependent recognition of double-stranded ribonucleic acids by retinoic acid-inducible gene-I and melanoma differentiation-associated gene 5, J Exp Med, 205, 1601, 10.1084/jem.20080091 · DOI · Paper page
- Manjunath, 2023, APOBEC3B drives PKR-mediated translation shutdown and protects stress granules in response to viral infection, Nat Commun, 14, 820, 10.1038/s41467-023-36445-9 · DOI
- Gao, 2020, m6A modification prevents formation of endogenous double-stranded RNAs and deleterious innate immune responses during hematopoietic development, Immunity, 52, 1007, 10.1016/j.immuni.2020.05.003 · DOI · Paper page
- Sadler, 2009, An antiviral response directed by PKR phosphorylation of the RNA helicase A, PLoS Pathog, 5, e1000311, 10.1371/journal.ppat.1000311 · DOI
- Fuchsová, 2002, The localization of nuclear DNA helicase II in different nuclear compartments is linked to transcription, Exp Cell Res, 279, 260, 10.1006/excr.2002.5617 · DOI
- Jeffrey, 1995, Nuclear localization of the interferon-inducible protein kinase PKR in human cells and transfected mouse cells, Exp Cell Res, 218, 17, 10.1006/excr.1995.1126 · DOI
- Kim, 2014, PKR is activated by cellular dsRNAs during mitosis and acts as a mitotic regulator, Genes Dev, 28, 1310, 10.1101/gad.242644.114 · DOI · Paper page
- Kim, 2021, RNA editing at a limited number of sites is sufficient to prevent MDA5 activation in the mouse brain, PLoS Genet, 17, e1009516, 10.1371/journal.pgen.1009516 · DOI
- Hu, 2023, ADAR1p150 prevents MDA5 and PKR activation via distinct mechanisms to avert fatal autoinflammation, Mol Cell, 83, 3869, 10.1016/j.molcel.2023.09.018 · DOI
- Murayama, 2024, Targeting DHX9 triggers tumor-intrinsic interferon response and replication stress in small cell lung cancer, Cancer Discov, 14, 468, 10.1158/2159-8290.CD-23-0486 · DOI
- Roulois, 2015, DNA-demethylating agents target colorectal cancer cells by inducing viral mimicry by endogenous transcripts, Cell, 162, 961, 10.1016/j.cell.2015.07.056 · DOI · Paper page
- Chen, 2021, Endogenous retroelements and the viral mimicry response in cancer therapy and cellular homeostasis, Cancer Discov, 11, 2707, 10.1158/2159-8290.CD-21-0506 · DOI · Paper page
- Jansz, 2021, Endogenous retroviruses in the origins and treatment of cancer, Genome Biol, 22, 147, 10.1186/s13059-021-02357-4 · DOI · Paper page
- Wu, 2022, PRMT inhibition induces a viral mimicry response in triple-negative breast cancer, Nat Chem Biol, 18, 821, 10.1038/s41589-022-01024-4 · DOI
Cited by
ADAR1 and ADAR2 associate with the RNA exosome and modulate RNA stability
Vukić, D., Du, Q., Cherian, A., Amoruso, D., Brožinová, K., Wacheul, L., Lacovich, V., Zorbas, C., Yadav, L., Sedmík, J., et al. (2026) · Nucleic Acids Research · doi:10.1093/nar/gkag381
Metadata
- Authors
- Cottrell, K. A., Ryu, S., Pierce, J. R., Soto Torres, L., Bohlin, H. E., Schab, A. M., & Weber, J. D.
- Affiliations
- 1Department of Medicine, Division of Molecular Oncology, Washington University School of Medicine, St. Louis, Missouri.
- 3Department of Biochemistry, Purdue University, West Lafayette, Indiana.
- ORCID
- Venue
- Cancer Research Communications
- Published
- 2024-04-04
- Volume
- 4
- Issue
- 4
- Pages
- 986-1003
- ISSN
- 2767-9764
- Cited by
- 40
- References
- 8
- Language
- en
- Funders
- HHS | National Institutes of Health (R01CA262804, K99MD016946, R00MD016946, R25HG006687, T32GM148405)
- U.S. Department of Defense (W81XWH-18-1-0025, W81XWH-21-10466)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Induction of Viral Mimicry Upon Loss of DHX9 and ADAR1 in Breast Cancer Cells. https://app.cochat.ai/papers/10.1158/2767-9764.crc-23-0488
- The paper
- Cottrell, K. A., Ryu, S., Pierce, J. R., Soto Torres, L., Bohlin, H. E., Schab, A. M., & Weber, J. D. (2024). Induction of Viral Mimicry Upon Loss of DHX9 and ADAR1 in Breast Cancer Cells. Cancer Research Communications. https://doi.org/10.1158/2767-9764.crc-23-0488
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.